This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> CureVac (CVAC) upgraded to Buy from Neutral at UBS; tgt raised to $18
Downgrades:
> Cognizant Tech (CTSH) downgraded to Underperform from Market Perform at MoffettNathanson; tgt lowered to $60
> DXC Technology (DXC) downgraded to Underperform from Market Perform at MoffettNathanson; tgt lowered to $28
Others:
> Alpine Immune Sciences (ALPN) initiated with an Overweight at Morgan Stanley; tgt $17
> CF Industries (CF) initiated with an Overweight at Wells Fargo; tgt $110
> Corteva (CTVA) initiated with an Overweight at Wells Fargo; tgt $78
> FMC Corp (FMC) assumed with an Overweight at Wells Fargo; tgt $148
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Source: Read Full Article
-
Germany to approve sending heavy battle tanks to Ukraine, says source
-
4 Retail Areas Set to Win in 2023 Holiday Season: Stock Picks
-
Opening Bell Analysts Research Calls for Tuesday, February 28
-
Earnings Preview: Antero Resources, Ford, Meta Platforms, Qualcomm
-
Four WD-40 Company Officers Are Bullish, Buying More Stock in the Q2 Trading Window

